BACKGROUND

Dr. Stokes is a Professor at the University of Hawaiʻi, and Chaminade University, in Honolulu, Hawaii, USA. They are an NSF/NIH funded researcher and educator, teaching a range of undergraduate and graduate courses in Biology/Medicine, Technology Commercialization. Dr.Stokes has also founded over half a dozen startup companies, is an inventor on multiple patents, is a Fellow of the Royal Society of Biology, and is an advocate for intersex rights, recognition, equity and inclusion.

Education

• Ph.D. 2005, Molecular Physiology, University of Warwick, UK
• M.Sc. 1996, MSc International Biotechnology, UK
• H.B.O. 1996 (~B.Eng) Bioengineering, Avans University of Applied Sciences, NL
• B.Sc. (Hons) 1995, Molecular Physiology, University of Warwick, UK

Research Interests

Dr. Stokes interests are in ion channel biology, data science and data visualization, and business development.

Recent Publications

• Myrcene and terpene regulation of TRPV1. Jansen C, Shimoda LMN, Kawakami JK, Ang L, Bacani AJ, Baker JD, Badowski C, Speck M, Stokes AJ, Small-Howard AL, Turner H. Channels (Austin). 2019 Dec;13(1):344-366. doi: 10.1080/19336950.2019.1654347. Channels (Austin). 2019 PMID:31446830

• Insulin-induced lipid body accumulation is accompanied by lipid remodeling in model mast cells. Aldan JT, Jansen C, Speck M, Maaetoft-Udsen K, Cordasco EA, Faiai M, Shimoda LMN, Greineisen WE, Turner H, Stokes AJ. Adipocyte. 2019 Dec;8(1):265-279. doi: 10.1080/21623945.2019.1636624. Adipocyte. 2019 PMID:31311389

• In vitro exposure to Hymenoptera venom and constituents activates discrete ionotropic pathways in mast cells. Jansen C, Shimoda LMN, Starkus J, Lange I, Rysavy N, Maaetoft-Udsen K, Tobita C, Stokes AJ, Turner H. Channels (Austin). 2019 Dec;13(1):264-286. doi: 10.1080/19336950.2019.1629225. Channels (Austin). 2019 PMID:31237176
• Diverse TRPV1 responses to cannabinoids. Starkus J, Jansen C, Shimoda LMN, Stokes AJ, Small-Howard AL, Turner H. Channels (Austin). 2019 Dec;13(1):172-191. doi: 10.1080/19336950.2019.1619436. Channels (Austin). 2019 PMID:31096838 | PMCID:PMC6557596

• Calcium-dependent, non-apoptotic, large plasma membrane bleb formation in physiologically stimulated mast cells and basophils. Jansen C, Tobita C, Umemoto EU, Starkus J, Rysavy NM, Shimoda LMN, Sung C, Stokes AJ, Turner H. J Extracell Vesicles. 2019 Feb 20;8(1):1578589. doi: 10.1080/20013078.2019.1578589. eCollection 2019. J Extracell Vesicles. 2019 PMID:30815238 | PMCID:PMC6383620

• TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure”. Horton JS, Shiraishi T, Alfulaij N, Small-Howard AL, Turner HC, Kurokawa T, Mori Y, Stokes AJ. Channels (Austin). 2019 Dec;13(1):1-16. doi: 10.1080/19336950.2018.1547611. Channels (Austin). 2019 PMID:30424709 | PMCID:PMC6298697

• Cannabinoids, the Heart of the Matter. Alfulaij N, Meiners F, Michalek J, Small-Howard AL, Turner HC, Stokes AJ. J Am Heart Assoc. 2018 Jul 13;7(14). pii: e009099. doi: 10.1161/JAHA.118.009099. Review. No abstract available. J Am Heart Assoc.  2018 PMID:30006489 | PMCID:PMC6064852

Patents

Method and system for simulating, predicting, interpreting, comparing, or visualizing complex data. WO2018140839A1

Methods and compositions for prevention and treatment of cardiac hypertrophy, US10137123B2